Antigen Express, Inc.
Antigen Express is a platform technology and product based company focused on immunotherapy of cancer and other unmet medical needs. The company has developed a proprietary synthetic peptide based approach for antigen-specific activation of critical members of the immune system, CD4+ T helper cells. The technology has shown promising results in a controlled, randomized Phase II clinical trial of its lead compound in breast cancer patients. Virtually any protein antigen is amenable to modification by Antigen Express technology to increase the specific activation of CD4+ T cells. The company is headquartered in Worcester, MA.Back to list